Annual Report

Overview

The report is Zhongzhi Pharmaceutical Holdings Limited's ninth ESG report and covers the Group's strategy and performance for 1 January to 31 December 2024. It describes Board-led ESG decision-making, a coordinating ESG Working Committee, and a comprehensive materiality assessment. The company reports Scope 1 and Scope 2 emissions, total energy and water consumption, hazardous and non-hazardous waste, employee composition, and work-related fatalities. It also sets out resource-efficiency, safety, supply-chain, product-quality, employee, and community initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 26 March 2025
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services